¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"double vessel disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • Legg-Calve-Perthes disease
    ·¹±×-Ä®º£-Æä¸£Å×½ºº´
  • legionnaires¡¯ disease
    ÀçÇⱺÀκ´
  • Leigh disease
    ¸®º´
  • life style disease
    »ýȰ½À°üº´
  • light chain disease
    °¡º­¿î»ç½½º´, °æ¼âº´
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • liver disease
    °£Áúȯ, °£º´
  • lower motor neuron disease
    ¾Æ·¡¿îµ¿½Å°æ¼¼Æ÷º´, ÇÏÀ§¿îµ¿½Å°æ¿øº´
  • lysosomal storage disease
    ¿ëÇØ¼ÒüÃàÀûº´, ¸®¼ÒÁ»ÃàÀûº´
  • Mikulicz¡¯s disease
    ¹ÌÄð¸®Ä¡º´
  • Minamata disease
    ¹Ì³ª¸¶Å¸º´
  • miner¡¯s disease
    ±¤ºÎº´
  • minimal change disease
    ¹Ì¼¼º¯È­º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • kidney disease
    ÄáÆÏº´, ½ÅÀ庴
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • liver disease
    °£º´, °£Áúȯ
  • luetic heart disease
    ¸Åµ¶½ÉÀ庴
  • lung disease
    Æóº´
  • lysosomal storage disease
    ¸®¼Ò¼ØÃàÀûº´, ¿ëÇØ¼ÒüÃàÀûº´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    (¢¡osteopetrosis) »À´ë¸®¼®Áõ, °ñÈ­¼®Áõ
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • medullary cystic disease
    ¼ÓÁú³¶¼ºº´, ¼ÓÁúÁÖ¸Ó´ÏÄáÆÏº´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°°¨¿°º´
  • meteorotropic disease
    ±â»óº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë ¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adrenal cortex disease
    ºÎ½ÅÇÇÁúÁúȯ(Üùãìù«òõòðü´).
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • albers-sch berg disease
    ¾Ëº£¸£½º-½¨º£¸£Å© º´(¡­Ü»)
  • albers-schonberg disease
    ¾Ëº£¸£½º-½¨º£¸£Å©º´(¡­Ü»)
  • alcoholic liver disease
    ¾ËÄڿüº °£Áúȯ(¡­àõ ÊÜòðü´)
  • alexanders disease
    ¾Ë·º»ê´õ º´(¡­Ü»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
DPPC dipalmitoylphosphatidylcholine; double-blind placebo-controlled trial
dpst double-pole single-throw [switch]
ds double-stranded
DSB double-strand break
DSDDT double sampling dye dilution technique
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
ADV Aujeszky Disease Virus
AITD Autoimmune Thyroid Disease
ATD Autoimmune thyroid disease
ADPKD Autosomal Dominant Polycystic Kidney Disease
ARPKD Autosomal recessive polycystic kidney disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Majocci's disease
    ¸¶¿äŰ º´
    Àڹݺ´.
  • Malassez's disease
    ¸»¶ó¼¼ º´
    °íȯÀÇ ³¶Æ÷.
  • manager disease
    ¸Å´ÏÀú º´
    ¿©·¯ °¡Áö º¹ÀâÇÑ ¾÷¹«¿¡ ¹Ù»Ú°Ô ½Ã´Þ¸®´Â °ü¸® Á÷±ÞÀÇ »ç¶÷¿¡°Ô¼­ ÈçÈ÷ º¼ ¼ö ÀÖ´Â º´. Çù½ÉÁõ, ƯÈ÷ °ü»ó µ¿¸Æ Ç÷ÀüÁõ µîÀÇ ½ÉÀå Ç÷°ü°è Áõ¼¼µé¸¸À» °¡¸®Å°´Â °ÍÀ̾ú´Âµ¥ Á¡Â÷·Î È®´ëµÇ¾î ¼ÒÈ­¼º ±Ë¾ç, ´ç´¢º´, ³ëÀÌ·ÎÁ¦, Ç÷¾Ð Àå¾Ö µîµµ Æ÷ÇԵȴÙ.
  • maple syrum urine disease
    ´Üdz ³ª¹« ½Ã·´ º´
    Ãø¼â, ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê
  • maple syrup urine disease
    ´Üdz ´ç¹Ð ´¢ Áúȯ
    Ãø¼â ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê[valine, leucine, isoleucine]ÀÇ ½ÉÇÑ Áõ°¡¸¦ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÀû Ư¡Àº Á¤½Å Áöü ¹ß´Þ Áö¿¬, Æ÷À¯ °ï¶õ, ¿äÃë µîÀÌ´Ù.
  • marble bone disease
    °ñ È­¼®Áõ, ´ë¸®¼® °ñº´
    ´ß ¹éÇ÷º´ À°Á¾±º¿¡ ¼ÓÇÏ´Â º´. °ñÇü ¸²ÇÁÁ¾À̶ó°íµµ ÇÏ´Â ÀÌ º´Àº, »À°¡ ±½¾îÁö´Â °ÍÀÌ Æ¯Â¡À̸ç, ¹ß»ýÀÌ µå¹°±â ¶§¹®¿¡ °æÁ¦ÀûÀ¸·Î Å« ¶æÀº ¾ø´Ù. Ç÷±¸¿Í ÀüÇô °ü°è¾øÀÌ »À ¼¼Æ÷°¡ Áõ½ÄÇϹǷΠÇ÷±¸¿¡¼­ À¯·¡ÇÏ´Â Á¾¾çÀÌ ¾Æ´Ï¶ó, ¹éÇ÷º´°ú °°Àº ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ÀϾ´Â º´À̱⠶§¹®¿¡ ¹éÇ÷º´À¸·Î Ãë±ÞµÈ´Ù.
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ì º´
    ³ú·®ÀÇ ÁøÇ༺ ÅðÇà º¯¼ºÀ¸·Î¼­ ÁøÇ༺ ÁöÀû ȲÆó, Á¤¼­ Àå¾Ö, Âø¶õ, ȯ°¢, ÁøÀü, °­Á÷, °æ·ÃÀÌ Æ¯Â¡. ÁÖ·Î Á߳⠳²ÀÚ Áß ¾ËÄÝ Áßµ¶ÀÚ, ƯÈ÷ ´Ù·®ÀÇ »ýÆ÷µµÁÖ¸¦ ¸¶½Ã´Â »ç¶÷¿¡°Ô Àß °É¸®´Â µå¹® Áúº´ÀÌ´Ù.
  • Marek's disease
    ¸¶·¹Å© º´
    Æ÷Áø ¹ÙÀÌ·¯½º
  • margarine disease
    ¸¶°¡¸° º´
    ´ÙÇü¼º È«¹ÝÀ¸·Î¼­ oleomargarineÁßÀÇ À¯È­Á¦°¡ ¿øÀÎÀÌ´Ù. µ¶ÀÏ, ¿À¶õ´Ù¿¡¼­ Æø¹ßÀûÀ¸·Î À¯ÇàÇÏ¿´À¸¸ç ´ç½Ã´Â Àü¿°¼ºÀ̶ó°í »ý°¢Çß´Ù.
  • medullary cystic disease
    ¼öÁú³¶¼º Áúȯ
  • mental disease
    Á¤½Åº´
    ±â´ÉÀû ¿øÀΰú ±âÁúÀûÀÎ ¿øÀÎÀ» Æ÷ÇÔÇÑ ¸ðµç Á¤½Åº´.
  • metabolic bone disease
    ´ë»ç¼º °ñ Áúȯ
  • metabolic disease
    ´ë»ç¼º Áúȯ
    ½Åü ¼¼Æ÷ÀÇ È­ÇйÝÀÀÀÇ Àå¾Ö°¡ ¿øÀÎÀÌ µÇ´Â Áúȯ.
  • Mikulicz's disease
    ¹ÌŬ¸¯Âê¾¾º´, ¹ÌÄð¸®Ã÷º´
    ¹ÌÁöÀÇ ¿øÀο¡ ÀÇÇÑ ´©¼± ¹× Ÿ¾×¼±ÀÇ ¾ç¼º ÀÚ±â ÇÑÁ¤¼º ¸²ÇÁ±¸ ħÀ±°ú Á¾Ã¢À¸·Î¼­, Á߳⠶Ǵ ³ë³âÀÇ ºÎÀο¡°Ô ¹ßº´ÇÑ´Ù. Sjögren ÁõÈıº°ú µ¿ÀÏÇÏ´Ù°í »ý°¢ÇÏ´Â »ç¶÷µéµµ ÀÖ´Ù. ¶Ç´Â °øÅëÀÇ º´ÀÎÀ» °¡Áø µ¿ÀÏ ÁúȯÀÇ ÀÌÇüÀ̶ó°í ÇÏ´Â »ç¶÷µµ ÀÖ´Ù. À¯À°Á¾Áõ, ¾Ç¼º ¸²ÇÁÁ¾, ±³¿øº´ µî¿¡¼­ µ¿ÀÏÇÑ ÀÓ»ó ¼Ò°ßÀ» º¼ ¶§, Mikulicz ÁõÈıºÀ̶ó°í ÇÑ´Ù.
  • mitral valvular disease
    ½Â¸ðÆÇ¸· Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
canavan disease Spongy degeneration of cerebral white matter, a rare autosomal recessive form of leukodystrophy. It is characterised by early onset, widespread demyelination and vacuolation of the white matter that gives rise to a spongy appearance, severe mental retardation, megalocephaly, atony of the neck muscles, spasticity of the extremities, and blindness. Death occurs at about 18 months of age.
(12 Dec 1998)
Canavan's disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
Canavan-van Bogaert-Bertrand disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
cancer, hodgkin's disease A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
canine parvovirus disease An acute disease of dogs with a variable mortality rate caused by the canine parvovirus; seen in three distinct clinical forms; a generalised neonatal disease, a severe nonsuppurative myocarditis, and a frequently fatal enteritis.
(05 Mar 2000)
carcinoid heart disease Cardiac manifestation of malignant carcinoid syndrome. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves.
(12 Dec 1998)
caroli disease <radiology> Communicating, cavernous ectasia of the intrahepatic bile ducts, rare, autosomal recessive, usually detected in young adults, no cirrhosis or portal hypertension, predisposed to calculus formation, benign course, but.. Recurrent cholangitis most likely to be liver abscesses most likely to be death, associated with medullary sponge kidney (renal tubular ectasia) in 80%
(12 Dec 1998)
caroli's disease Congenital cystic dilatation of the intrahepatic bile ducts. It consists of 2 types: simple, with bile duct dilatation or ectasia alone, and complex, with associated extensive hepatic fibrosis and portal hypertension. Benign renal tubular ectasia is associated with both types.
(12 Dec 1998)
rabbit haemorrhagic disease A highly infectious disease of rabbits, caused by a calicivirus and characterised by haemorrhagic lesions, particularly affecting the lungs and liver; since it was first identified in China in 1984, it has been reported from Korea, it has spread through Europe, and it has reached North Africa and Mexico.
(05 Mar 2000)
machado-joseph disease A progressive degenerative disease of the central nervous system occurring in portuguese-azorean families, having a variety of forms and inherited as an autosomal dominant trait. There are four major types: type I: with pyramidal and extrapyramidal deficits; type II: with cerebellar, pyramidal and extrapyramidal deficits; type III: with cerebellar deficits and distal sensorimotor neuropathy; type IV: with parkinsonism and distal sensory neuropathy. It was originally reported in two portuguese-azorean families in massachusettes (machado), then in another portuguese family (thomas), and later in a third family in california (joseph, who settled there in 1845). It has been reported also in japanese families.
(12 Dec 1998)
Paas' disease A familial skeletal deformation marked by coxa valga, double patella, shortening of the middle and terminal phalanges of fingers and toes, deformities of the elbows, scoliosis, and spondylitis deformans of the lumbar vertebrae; all of these manifestations may be unilateral or bilateral.
(05 Mar 2000)
Gairdner's disease <disease> Attacks of cardiac distress accompanied by apprehension.
Synonym: angina pectoris sine dolore, angor pectoris.
(05 Mar 2000)
Pacheco's disease A highly contagious, acute disease of psittacine birds caused by a herpesvirus and characterised by bright yellow urates with scant faeces, icterus, and terminal anorexia.
(05 Mar 2000)
Pacheco's parrot disease virus Probably a virus of the family Herpesviridae, possibly related to the virus of infectious laryngotracheitis.
Synonym: parrot virus.
(05 Mar 2000)
vagabond's disease Excoriations and melanoderma caused by scratching the bites of the body louse, Pediculus corporis.
Synonym: Greenhow's disease, vagabond's disease, vagrant's disease.
Racial melanoderma, the normally dark skin of blacks and certain other races.
Senile melanoderma, cutaneous pigmentation occurring in the aged.
Synonym: melasma universale.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á